147 related articles for article (PubMed ID: 7292370)
1. [Chemotherapy of malignant Hodgkin lymphoma].
Brunner K; Joss R
Ther Umsch; 1981 Sep; 38(9):893-8. PubMed ID: 7292370
[No Abstract] [Full Text] [Related]
2. [Results in the chemotherapy of malignant lymphomas].
Jahn H; Syrbe G; Kühn RA; Ruffert K; Jorke D; Katenkamp D; Kob D; Löbe LP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):691-3. PubMed ID: 6172335
[No Abstract] [Full Text] [Related]
3. [Chemotherapy in non-Hodgkin lymphoma].
Bremer K; Meusers P; Brittinger G
Internist (Berl); 1980 Sep; 21(9):512-28. PubMed ID: 7005175
[No Abstract] [Full Text] [Related]
4. [Burkitt lymphoma].
Santoro G; Rocco P
G Chir; 1996; 17(8-9):405-7. PubMed ID: 9004834
[TBL] [Abstract][Full Text] [Related]
5. Lymphomas.
Santoro A; Castagna L; Magagnoli M
Cancer Chemother Biol Response Modif; 2003; 21():399-428. PubMed ID: 15338757
[No Abstract] [Full Text] [Related]
6. [Curability of malignant lymphoma].
Fernández-Rañada JM
Rev Clin Esp; 1991 Nov; 189(8):382-5. PubMed ID: 1784803
[No Abstract] [Full Text] [Related]
7. [Hodgkin's disease].
Neretto G
Minerva Med; 1980 Feb; 71(6):440-4. PubMed ID: 7360384
[No Abstract] [Full Text] [Related]
8. [Chemotherapy of malignant lymphoma].
Alberto P
Cancro; 1973; 26(5):315-37. PubMed ID: 4793833
[No Abstract] [Full Text] [Related]
9. [Effectiveness of the cytostatic therapy in III-IV stages of lymphogranulomatosis].
Kolpikova LA; Orlova LD; Popov VM
Sov Med; 1978 Aug; (8):45-9. PubMed ID: 705455
[No Abstract] [Full Text] [Related]
10. [Current possibilities and trends in the treatment of malignant lymphomas].
Kálmán R
Orv Hetil; 1978 Sep; 119(38):2299-309. PubMed ID: 693034
[No Abstract] [Full Text] [Related]
11. [Hodgkin lymphoma: evolution and dilemma in radiation treatments].
Girinsky T; Ghalibafian M; Paumier A
Cancer Radiother; 2009 Oct; 13(6-7):479-81. PubMed ID: 19656714
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of malignant hemoreticulopathy].
Israël L
Rev Tuberc Pneumol (Paris); 1968; 32(5):666-7. PubMed ID: 4885657
[No Abstract] [Full Text] [Related]
13. [Hodgkin's disease in Northern Israel].
Cohen Y; Haim N; Ben Shahar M; Epelbaum R
Harefuah; 1985 Oct; 109(7-8):173-7. PubMed ID: 4076913
[No Abstract] [Full Text] [Related]
14. Rituximab in lymphocyte-predominant Hodgkin disease.
Azim HA; Pruneri G; Cocorocchio E; Cinieri S; Raviele PR; Bassi S; Preda L; Martinelli G; Peccatori FA
Oncology; 2009; 76(1):26-9. PubMed ID: 19033694
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy in malignant lymphoma.
Bronstein E; Geller W
Am J Roentgenol Radium Ther Nucl Med; 1966 Jan; 96(1):167-70. PubMed ID: 5321805
[No Abstract] [Full Text] [Related]
16. Skin involvement with Hodgkin disease: a rare condition late in the course of Hodgkin lymphoma.
Lowe GC; Hocker TL; Comfere NI; Lehman JS
Am J Hematol; 2013 Nov; 88(11):979. PubMed ID: 23686913
[No Abstract] [Full Text] [Related]
17. Management of early-stage Hodgkin's disease: a continuing evolution.
Golomb HM
Semin Oncol; 1998 Aug; 25(4):476-82. PubMed ID: 9728597
[TBL] [Abstract][Full Text] [Related]
18. Developing anticancer chemotherapy services in a developing country: Hodgkin lymphoma experience.
Chandra J; Naithani R; Singh V; Saxena YK; Sharma M; Pemde H
Pediatr Blood Cancer; 2008 Oct; 51(4):485-8. PubMed ID: 18636462
[TBL] [Abstract][Full Text] [Related]
19. [On the problem of combined chemotherapy in malignant lymphogranulomatosis].
Obrecht P; Melchert F; Boutis L
Verh Dtsch Ges Inn Med; 1968; 74():641-4. PubMed ID: 5714405
[No Abstract] [Full Text] [Related]
20. [Medicinal therapy of malignant lymphomas].
Aul C; Schroeder M; Giagounidis A
Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
